# OnCo record getug-afu-17 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/getug-afu-17/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "getug-afu-17", "NCT00667069" ;
  schema:name "GETUG-AFU 17"@en ;
  schema:alternateName "GETUG-AFU 17"@en, "GETUG 17"@en ;
  schema:description "The French version of the same question, and the same answer: treating everyone straight after surgery does not help, and it doubles the rate of lasting bladder and erection problems."@en ;
  schema:url <https://onco.cc/trials/getug-afu-17/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00667069>, <https://doi.org/10.1016/S1470-2045(20)30454-X> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/>, <https://onco.cc/cancers/prostate-bcr/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:drugs <https://onco.cc/drugs/triptorelin/> ;
  onco:companies <https://onco.cc/companies/unicancer/>, <https://onco.cc/companies/ipsen/> ;
  onco:terms <https://onco.cc/terms/prostatectomy/>, <https://onco.cc/terms/salvage-therapy/>, <https://onco.cc/terms/biochemical-recurrence/>, <https://onco.cc/terms/qol-pro/> ;
  onco:trials <https://onco.cc/trials/radicals-rt/>, <https://onco.cc/trials/raves/>, <https://onco.cc/trials/artistic-meta-analysis/> .